Preparing a financial incentive program to improve retention in HIV care and viral suppression for scale: using an implementation science framework to evaluate an mHealth system in Tanzania.

ART Conditional Cash Transfers HIV/ADS Implementation Science Retention in Care Viral Suppression

Journal

Implementation science communications
ISSN: 2662-2211
Titre abrégé: Implement Sci Commun
Pays: England
ID NLM: 101764360

Informations de publication

Date de publication:
23 Sep 2021
Historique:
received: 21 05 2021
accepted: 06 09 2021
entrez: 24 9 2021
pubmed: 25 9 2021
medline: 25 9 2021
Statut: epublish

Résumé

Viral suppression is key to ending the HIV epidemic, yet only 58% of people living with HIV (PLHIV) in sub-Saharan Africa are suppressed. Cash transfers are an effective strategy to improve retention in care, but little is known about optimization of implementation; for example, designing effective programs that integrate into existing clinic workflows. We studied implementation of an mHealth system to deliver cash transfers to support retention. We conducted a mixed-methods study assessing implementation of an mHealth cash transfer study. This was part of a larger, hybrid implementation-effectiveness randomized controlled trial evaluating cash transfers conditional on visit attendance for viral suppression among Tanzanian PLHIV initiating ART. An mHealth system using fingerprint identification and mobile payments was used to automatically disburse mobile money to eligible PLHIV. We used Proctor's framework, assessing implementation of the mHealth system from the perspectives of PLHIV and clinicians. We analyzed mHealth system data and conducted surveys (n = 530) and in-depth interviews (n = 25) with PLHIV, clinic and pharmacy staff (n = 10), and structured clinic observations (n = 2293 visits). One thousand six hundred fifty-one cash transfers were delivered to 346 PLHIV in the cash arms, 78% through mobile money. Among those in the cash arms, 81% registered their mobile money account with the mHealth system by study end, signaling high adoption. While acceptability for fingerprinting and mobile payments was high among PLHIV, interviews revealed mixed views: some had privacy concerns while others felt the system was secure and accurate, and provided some legitimacy to the clinical visits. Pharmacists praised system efficiency, but concerns about duplicative recordkeeping and added work arose. Clinic staff voiced excitement for the system's potential to bring the cash program to all patients and simplify workflows; yet concerns about multiple systems, staffing, and intermittent connectivity tempered enthusiasm, highlighting structural issues beyond program scope. Structured observations revealed a steep learning curve; repeat fingerprint scans and manual entry declined as the system improved. Biometric identification and mobile payments were acceptable to most patients and staff. Fingerprinting encountered some feasibility limitations in the first months of testing; however, mobile payments were highly successful. Biometric identification and mobile payments may provide a scalable mechanism to improve patient tracking and efficiently implement financial incentives in low-resource settings. Name of the registry: clinicaltrials.gov Trial registration number: NCT03351556 Date of registration: 11/24/2017 Checklists: StaRI (included with submission). Note CONSORT for cluster-randomized trials was used for the main trial but is not directly applicable to this manuscript.

Sections du résumé

BACKGROUND BACKGROUND
Viral suppression is key to ending the HIV epidemic, yet only 58% of people living with HIV (PLHIV) in sub-Saharan Africa are suppressed. Cash transfers are an effective strategy to improve retention in care, but little is known about optimization of implementation; for example, designing effective programs that integrate into existing clinic workflows. We studied implementation of an mHealth system to deliver cash transfers to support retention.
METHODS METHODS
We conducted a mixed-methods study assessing implementation of an mHealth cash transfer study. This was part of a larger, hybrid implementation-effectiveness randomized controlled trial evaluating cash transfers conditional on visit attendance for viral suppression among Tanzanian PLHIV initiating ART. An mHealth system using fingerprint identification and mobile payments was used to automatically disburse mobile money to eligible PLHIV. We used Proctor's framework, assessing implementation of the mHealth system from the perspectives of PLHIV and clinicians. We analyzed mHealth system data and conducted surveys (n = 530) and in-depth interviews (n = 25) with PLHIV, clinic and pharmacy staff (n = 10), and structured clinic observations (n = 2293 visits).
RESULTS RESULTS
One thousand six hundred fifty-one cash transfers were delivered to 346 PLHIV in the cash arms, 78% through mobile money. Among those in the cash arms, 81% registered their mobile money account with the mHealth system by study end, signaling high adoption. While acceptability for fingerprinting and mobile payments was high among PLHIV, interviews revealed mixed views: some had privacy concerns while others felt the system was secure and accurate, and provided some legitimacy to the clinical visits. Pharmacists praised system efficiency, but concerns about duplicative recordkeeping and added work arose. Clinic staff voiced excitement for the system's potential to bring the cash program to all patients and simplify workflows; yet concerns about multiple systems, staffing, and intermittent connectivity tempered enthusiasm, highlighting structural issues beyond program scope. Structured observations revealed a steep learning curve; repeat fingerprint scans and manual entry declined as the system improved.
CONCLUSIONS CONCLUSIONS
Biometric identification and mobile payments were acceptable to most patients and staff. Fingerprinting encountered some feasibility limitations in the first months of testing; however, mobile payments were highly successful. Biometric identification and mobile payments may provide a scalable mechanism to improve patient tracking and efficiently implement financial incentives in low-resource settings.
TRIAL REGISTRATION BACKGROUND
Name of the registry: clinicaltrials.gov Trial registration number: NCT03351556 Date of registration: 11/24/2017 Checklists: StaRI (included with submission). Note CONSORT for cluster-randomized trials was used for the main trial but is not directly applicable to this manuscript.

Identifiants

pubmed: 34556176
doi: 10.1186/s43058-021-00214-w
pii: 10.1186/s43058-021-00214-w
pmc: PMC8461932
doi:

Banques de données

ClinicalTrials.gov
['NCT03351556']

Types de publication

Journal Article

Langues

eng

Pagination

109

Subventions

Organisme : NIMH NIH HHS
ID : R01 MH112432
Pays : United States
Organisme : NIMH NIH HHS
ID : R01MH112432-01A1
Pays : United States

Informations de copyright

© 2021. The Author(s).

Références

World Bank Econ Rev. 2012 Jun 1;26(2):165-190
pubmed: 24319306
AIDS. 2014 Mar;28 Suppl 2:S187-204
pubmed: 24849479
PLoS One. 2014 Jan 15;9(1):e85473
pubmed: 24454875
Adm Policy Ment Health. 2009 Jan;36(1):24-34
pubmed: 19104929
AIDS Behav. 2013 Sep;17(7):2283-92
pubmed: 23370833
Lancet HIV. 2019 Oct;6(10):e705-e714
pubmed: 31578955
AIDS Behav. 2021 Mar;25(3):814-825
pubmed: 32968885
AIDS Behav. 2014 Oct;18 Suppl 5:S505-15
pubmed: 23842717
AIDS Behav. 2015 Aug;19(8):1510-26
pubmed: 25096896
Lancet HIV. 2020 Nov;7(11):e762-e771
pubmed: 32891234
JMIR Mhealth Uhealth. 2018 Jan 05;6(1):e4
pubmed: 29305343
BMC Infect Dis. 2015 Oct 28;15:490
pubmed: 26520572
Lancet Glob Health. 2013 Dec;1(6):e362-70
pubmed: 25104601
Acad Emerg Med. 2005 Jul;12(7):617-21
pubmed: 15995093
Trials. 2020 Nov 23;21(1):963
pubmed: 33228757
BMJ Open. 2012 Feb 08;2:e000747
pubmed: 22318666
J Acquir Immune Defic Syndr. 2013 Jun 1;63(2):e56-63
pubmed: 23403860
Am Econ Rev. 2008 Dec 1;98(5):1829-1863
pubmed: 21687831
PLoS One. 2012;7(11):e49091
pubmed: 23145079

Auteurs

Laura Packel (L)

School of Public Health, University of California Berkeley, Berkeley, CA, USA. lpackel@berkeley.edu.

Carolyn Fahey (C)

School of Public Health, University of California Berkeley, Berkeley, CA, USA.

Atuganile Kalinjila (A)

Health for a Prosperous Nation, Dar es Salaam, Tanzania.

Agatha Mnyippembe (A)

Health for a Prosperous Nation, Dar es Salaam, Tanzania.

Prosper Njau (P)

Health for a Prosperous Nation, Dar es Salaam, Tanzania.
National AIDS Control Programme, Ministry of Health, Community Development, Gender, Elderly, and Children, Dodoma, Tanzania.

Sandra I McCoy (SI)

School of Public Health, University of California Berkeley, Berkeley, CA, USA.

Classifications MeSH